RecallDepth
Class II Ongoing

KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.

This recall is currently active, issued July 9, 2025. It was issued by Tailstorm Health Inc.

Company
Tailstorm Health Inc
Recall Initiated
June 2, 2025
Posted
July 9, 2025
Recall Number
D-0500-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
23,200 vials
Firm Location
Phoenix, AZ, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Distribution

Nationwide in the US

Lot / Code Info

Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027.

More recalls by Tailstorm Health Inc

View all recalls by this company →

Other recent Class II Drug recalls